You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Colorcon

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Novartis Vaccines and Diagnostics Inc. v. Biogen Idec Inc. (D. Del. 2011)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Novartis Vaccines and Diagnostics Inc. v. Biogen Idec Inc. (D. Del. 2011)

Docket   Start Trial Date Filed 2011-01-26
Court District Court, D. Delaware Date Terminated 2014-02-04
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand Plaintiff Referred To Mary Pat Thynge
Parties ALEXION PHARMACEUTICALS INC.; BIOGEN IDEC INC.; MEDIMMUNE LLC; NOVARTIS PHARMA AG; NOVARTIS VACCINES AND DIAGNOSTICS INC.
Patents 5,688,688
Attorneys Alissa K. Lipton; Alyssa D. Klapper; Amy Arnott Quinlan; Andrew Colin Mayo; Anthony Michael; Benjamin J. Schladweiler; Bo K. Moon; Brian E. Farnan; Charles E. Lipsey; Charles J. Hawkins; Christine Willgoos; Claire Laporte; Collins J. Seitz , Jr.; Daniel Marcus Attaway; David M. Conca; Diane K. Pang; Donald A. Ware; Elliot M. Olstein; Gerald J. Flattmann , Jr.; Jeremy A. Younkin; John C. Kappos; Kakoli Caprihan; Kenneth Laurence Dorsney; Linda A. Wadler; Marco J. Quina; Marcus Kretzschmar; Mary Matterer; Mary W. Bourke; Nicholas B. Janda; Petra Scamborova; Raymond M. Gabriel; Richard K. Herrmann; Sarah S. Burg; Steven J. Balick; Thomas P. Steindler; Tiffany Geyer Lydon
Firms Farnan LLP; Greenberg Traurig, the Nemours Building; Seitz Ross Aronstam & Moritz LLP; Womble Bond Dickinson (US) LLP
Link to Docket External link to docket
Biologic Drugs cited in Novartis Vaccines and Diagnostics Inc. v. Biogen Idec Inc.
The biologic drug covered by the patent cited in this case is   Start Trial .

Details for Novartis Vaccines and Diagnostics Inc. v. Biogen Idec Inc. (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-08-02 171 alleging infringement of U.S. Patent No. 5,688,688 ("the '688 patent"), entitled "Vector…non infringement and invalidity of the '688 patent. (D. I. 14, 17, 19) Medlmmune additionally seeks…declaratory judgment of unenforceability of the '688 patent. (D.I. 14) Also on July 6, 2011, Alexion filed … (D.I. 161) 2. Claim 1 of the '688 patent, reproduced below, describes a vector for expression…the transcription regulatory region. 2 ('688 patent at col. 75:43-56) In preparation for producing External link to document
2011-01-26 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,688,688;. (dmp, ) (Entered:…2011 4 February 2014 1:11-cv-00084 830 Patent Plaintiff District Court, D. External link to document
2013-04-29 419 Levine, Ph.D. concerning Invalidity of U.S. Patent No. 5,688,688 by Biogen Idec Inc. (Schladweiler, Benjamin…2011 4 February 2014 1:11-cv-00084 830 Patent Plaintiff District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Merck
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.